India's DCGI Mulls GMP Inspections Of API Plants Exporting To Europe
This article was originally published in PharmAsia News
Executive Summary
The Drug Controller General of India is considering inspections of the nation's bulk-drug plants for compliance with international good-manufacturing practices standards for their Europe-bound exports.